Clot-retrieval device safe, effective for treatment of chronic thrombus in DVT at 30 days Source:
Beasley R, et al. Late-breaking data and hot topics. Presented at: the International Symposium on Endovascular Therapy; May 9-11, 2021; Miami Beach, Florida (hybrid meeting). Disclosures:
The study was funded by Inari Medical. Beasley reports he has financial ties with Abbott, Boston Scientific, Cardinal Health/Cordis, Centerline Biomedical, Cook Medical, C.R. Bard/BD, Cardiovascular Systems Inc., Endologix, Inari Medical, Medtronic, MicroMedical Solutions, Penumbra, Philips/Volcano/Spectranetics, Terumo/Boston Scientific and W.L. Gore and Associates.
ADD TOPIC TO EMAIL ALERTS
Receive an email when new articles are posted on